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Background: Preeclampsia is a disorder with a reported incidence of 2%-8% among all pregnancies, accounting for
more than 50,000 deaths worldwide each year. In low- and middle- income countries maternal/perinatal morbidity
and mortality associated with preeclampsia are high due to the lack of proper prenatal and hospital care and
limited access to neonatal intensive care. The objectives of our study were to determine the association of long
interbirth interval (IBI) and preeclampsia and to investigate the interactions between long IBI and other risk factors
among multiparous women in Yerevan, Armenia.
Methods: We conducted a hospital-based case–control study among 36 multiparous women with preeclampsia
(cases) and 148 without preeclampsia (controls) during their last pregnancy, selected from the two largest maternity
hospitals in Armenia. The data were collected through telephone-based structured interviews and analyzed using
STATA software. The study applied univariate and multivariate logistic regression analyses.
Results: The study found a significant interaction between IBI and previous history of preeclampsia. Among
women without a history of previous preeclampsia, the odds of having preeclampsia among women with long IBI
(greater than or equal to five years) was 6.88 time higher compared to those with short IBI (CI: 1.75-27.05; p = 0.006)
after adjusting for confounders; among women with a history of previous preeclampsia the odds ratio was 0.60
(CI: 0.07-4.99; p = 0.638). The final fitted model for preeclampsia among multiparous women who had planned
their pregnancies included IBI, time to pregnancy, Body Mass Index, method of contraception and household
monthly income.
Conclusions: Long IBI appeared to be a strong risk factor for preeclampsia development only among women
without a history of previous preeclampsia. This finding may contribute to a new approach in understanding the
etiology of preeclampsia and may be useful for developing further recommendations for this particular subgroup
of women that are at higher risk for preeclampsia development in subsequent pregnancies.Background
Preeclampsia has been termed as a “disease of theories”,
reflecting the confusion that surrounds its causes and
pathophysiology [1]. Preeclampsia is a disorder with a
reported incidence of 2%-8% among all pregnancies, ac-
counting for more than 50,000 deaths worldwide each
year [2]. Even in countries with low maternal mortality
rates, a substantial proportion of maternal mortalities is
due to preeclampsia/eclampsia [3]. Preeclampsia also* Correspondence: aharutyunyan@aua.am
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distribution, and reproduction in any mediumaffects the infants’ well-being, leading to poor intrauter-
ine growth, prematurity and high perinatal mortality
rates [4]. In developing countries, the lack of proper pre-
natal and hospital care, and limited access to neonatal
intensive care lead to higher maternal/perinatal mor-
bidity and mortality associated with preeclampsia [2-5].
Maternal mortality in Armenia has declined from 34.7
deaths per 100,000 live births in 1995 to 13.2 deaths per
100,000 live births in 2011, but it still exceeds the aver-
age rates for European Union (EU) new member states
(less than 10 maternal deaths per 100,000 live births)
and is noticeably higher than in EU-15 countries (less
than 6 maternal deaths per 100,000 live births) [6,7].entral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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of maternal mortality worldwide, including Armenia [2].
Despite extensive research exploring the risk factors
and the management of preeclampsia, there has been no
improvements in predicting who would develop pre-
eclampsia, and there are no protocols for prevention or
treatment for this condition other than delivery (even if
it is a preterm delivery).
Preeclampsia in primiparous women is 4–5 times more
prevalent than multiparous women who have had a pre-
vious normal pregnancy [8-11]. Moreover, multiparous
women have milder symptoms and most are recurrent
cases [12]. Other factors associated with preeclampsia are
maternal age [8,10], family history of preeclampsia [8,13],
level of education [14], high Body Mass Index (BMI)
[8,9,15,16], pre-existing medical conditions such as chronic
hypertension, renal diseases, diabetes- including gestational
diabetes [8,15], and others.
Few studies have investigated risk factors for pre-
eclampsia development among multiparous women. Re-
ported risk factors of preeclampsia for multiparous
women include interbirth interval (IBI) [15,17-19], part-
ner change [11,20,21], previous low birth weight delivery
and preterm deliveries [18], and history of previous pre-
eclampsia [8-11,15]. The literature suggests that longer
IBI increases the risk of preeclampsia, indicating that the
protective effect of past pregnancies may decline over
time or that other time dependent factors contribute to
increased risk [22]. Although different studies have used
different time intervals, most report a significant associ-
ation between long IBI and increased risk of preeclamp-
sia. Although the exact length of the interval where the
risk of preeclampsia begins to increase is not clear, IBIs
of five years or more are associated with increased risk
of preeclampsia [17].
The objectives of this study were to explore risk
factors (including IBI) for preeclampsia and to investi-
gate interactions between IBI and other risk factors
among reproductive age multiparous women in Yerevan,
Armenia.
Methods
We conducted a case–control study among women of
reproductive age (18–44) living in Yerevan who were
admitted to the Institute of Obstetrics (Perinatology),
Gynecology and Reproductive Health and the Erebuni
Medical Center for delivery from the 1st of January 2008
to the 1st of April 2009. These two maternity hospitals
are the largest referral tertiary care centers in Armenia
and are responsible for one-third of all deliveries in
Yerevan.
Cases were women living in Yerevan who were
diagnosed with preeclampsia in the last pregnancy in
the selected maternity hospitals. The definition of apreeclampsia case status was based on the US National
Heart Lung and Blood Institute (NHLBI) criteria for
diagnosis of this condition [23]. Controls were defined as
reproductive age women living in Yerevan that gave birth
in the same maternity hospitals with no diagnosis of
preeclampsia during their last pregnancy.
After receiving permission from the directors of the
two maternity hospitals, a member of the research team,
an OB/GYN, identified cases and controls while com-
pleting data abstraction forms during the review of the
medical records. All cases who were identified were
selected for inclusion into the study. The study used an
incidence-density sampling approach for selecting con-
trols. Three controls without preeclampsia were randomly
sampled using a random number table from all eligible
women that gave birth in the selected maternity hospitals
in the same month when a case was diagnosed with pre-
eclampsia. Overall, 102 eligible cases and 306 controls
from the registries of the two maternity hospitals were
selected for a larger study. From this larger study popula-
tion, the current study excluded all primiparous women
and conducted an analysis of the remaining 36 cases and
148 controls.
An interviewer-administered structured questionnaire
was used for data collection by telephone for both cases
and controls Additional file 1. During the telephone
interview, oral consent was obtained from each par-
ticipant. The research team designed the questionnaire,
which included questions adopted from questionnaires
used in other studies to investigate risk factors for
preeclampsia development and questions added by the
researchers adopted from other instruments [24-26].
The questionnaire was pre-tested among five reproduct-
ive age women through telephone interviews.
The dependent (outcome) variable of the study was
preeclampsia status during the last pregnancy that was
clinically confirmed by a doctor at the maternity hospital
and checked by the researchers against the US NHLBI
criteria. The main independent variables were IBI, age,
educational level, parity, type of contraceptive used
within one year before the pregnancy, time to pregnancy
(TTP), family history of preeclampsia, history of previ-
ous preeclampsia, BMI, chronic hypertension, and renal
disease.
The IBI was calculated as the interval in years between
the dates of the two last deliveries. The IBI was analyzed
both as a continuous and a dichotomous variable defined
as short (<5 years) and long (≥5 years). The TTP, as a
marker of fecundity, was defined as the time interval in
months required for a couple to conceive from the start of
unprotected intercourse and was used as dichotomous
variable with a cut-point of 12 months. The method of
contraception was included as a dichotomous variable
defined as barrier (condoms, diaphragms, spermicides and
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[27]. The BMI, calculated as pre-pregnancy weight
(kilograms) per height squared (meters squared), and age
were analyzed as continuous variables.
To assess the relationships between each independent
variable and the dependent variable and to identify
confounders for the relationship between IBI and pre-
eclampsia status, the study performed univariate logistic
regressions. All identified confounders were included in
the multivariate logistic regression model. Categorical
data were converted into “dummy” variables for the
regression analysis. The study applied multivariate logistic
regression models to control for potential confounders
and explore potential effect modification and, ultimately,
to calculate the adjusted odds ratios and 95% confidence
intervals to estimate the strength of associations between
independent and dependent variables. Multivariate logis-
tic regression analysis was also used to produce a final
fitted model. Each full model was tested against the
nested model using Akaike’s Information Criteria (AIC)
which is an approximation to the cross-validated predic-
tion error (e.g. criteria for determining the “best model”).
The model fit was tested with Hosmer-Lemeshow good-
ness of fit test. Using the alpha error of 0.05, we calculated
the actual statistical power based on the proportions of
the primary variable (IBI) and the actual sample size of 36
cases and 148 controls and the power was 0.99.
The Institutional Review Board/Committee on Human
Research (IRB) of the American University of Armenia
approved the study.
Results
From 102 eligible cases and 306 controls selected from
the registries of two maternity hospitals for telephone-Table 1 Descriptive characteristics of multiparous preeclamps
Variable Cas
Age at delivery (years) (SD)* 3
BMI (kg/m2) (SD)* 2
Renal disease, % (n) 1
Women’s positive Rh factor, % (n) 7
Household monthly expenditure >100,000 AMD, % (n) 5
Barrier method of contraception, % (n) 4
Time to pregnancy ≥12 months, % (n) 4
Family history of preeclampsia, % (n) 2
IBI (years) (SD)* 7
Long IBI (≥5years), % (n) 6
Stillbirth in previous pregnancies, % (n) 1
History of previous preeclampsia, % (n) 4
BMI, Body Mass Index; IBI, Interbirth Interval.
*Mean (standard deviation).based interviews the study team failed to contact 23
subjects due to different reasons. Out of the contacted
385 subjects 17 refused to participate (4 cases and 13
controls) and 89 cases and 279 controls completed the
interviews. The response rate was 95.7% for cases and
95.5% for controls. We analysed the data of 184 multip-
arous women subsampled from the original sample.
Table 1 presents descriptive statistics of the 36 multipar-
ous cases and 148 controls. Cases were older compared
to controls, with the mean age of cases equal to 31.3
(SD: 5.9) vs. 28.1 (SD: 4.3). The cases had a higher BMI
than controls, with 25.5 kg/m2 (SD: 4.0) vs. 21.6 kg/m2
(SD: 3.6). Cases were more likely to have an IBI more
than five years compared to controls, with 63.9% vs.
26.7% respectively. Cases and controls were statistically
significantly different in age, BMI, IBI, renal disease, TTP,
family history of preeclampsia, number of stillbirths and
history of previous preeclampsia.
Univariate logistic regression analysis showed that age
at delivery, BMI, renal disease and TTP were sig-
nificantly associated with both preeclampsia status and
IBI, therefore confounding the relationship between pre-
eclampsia status and IBI.
Table 2 presents the association between preeclampsia
status and independent variables with no adjustment
and with adjustment for confounding variables. After
adjusting for age, BMI, and renal disease, the odds of
having preeclampsia was higher among women with
long IBI compared to women with short IBI (OR = 2.90;
95% CI: 1.07-7.86; p = 0.036). Although TTP was identi-
fied as a confounder, IBI was not adjusted for it because
of a large number of missing values for this variable as
only those who planned their pregnancy reported TTP
(111 multiparous women).ia cases and their multiparous controls
es n = 36 Controls n = 148 P value
1.3 (5.9) 28.1 (4,3) <0.0005
5.5 (4.0) 21.6 (3.6) <0.0005
3.9 (5) 2.7 (4) 0.015
6.5 (26) 91.2 (135) 0.016
5.9 (19) 60.2 (77) 0.065
7.2 (17) 34.5 (51) 0.155
0.0 (8) 11.0 (10) 0.004
0.6 (7) 5.1 (7) 0.008
.3 (4.5) 4.2 (2.8) <0.0005
3.9 (23) 26.7 (39) 0.0005
3.9 (5) 4.1 (6) 0.026
7.2 (17) 4.1 (6) <0.0005
Table 2 Association between interbirth interval and preeclampsia status with and without adjustment for confounders
Variable Univariate analysis Multivariate analysis
Unadjusted OR 95% CI Adjusted OR* 95% CI
IBI (years)
<5 1.00
≥5 5.26 2.39-11.57 2.90 1.07-7.86
Age at delivery (years) 1.14 1.06-1.24 1.03 0.93-1.14
BMI (kg/m2) 1.26 1.14-1.40 1.23 1.11-1.37
Renal disease
No 1.00 1.00
Yes 5.81 1.47-22.87 0.98 0.16-5.96
BMI, Body Mass Index; IBI, Interbirth Interval.
*Adjusted for all variables in Table 2.
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The research team checked for possible interactions be-
tween IBI and other independent variables and identified
a statistically significant interaction between history of
previous preeclampsia and the IBI (Table 3). The inter-
action term between IBI with the cut-point of 5 years
and history of previous preeclampsia after adjusting for
age, BMI and renal disease was 0.09 (95% CI: 0.01-0.96;
p = 0.046). Among women without history of previous
preeclampsia after adjusting for age, BMI and renal
disease the odds ratio (OR) was 6.88 (95% CI: 1.75-27.05;
p = 0.006), suggesting about seven fold increase in the
odds of preeclampsia development among those with long
IBI compared to those with short IBI. Among women
with the history of previous preeclampsia, association
between IBI and preeclampsia status was not statistically
significant (OR = 0.66; 95% CI: 0.07-4.99; p = 0.638)
(Table 3).
Table 4 presents the unadjusted and adjusted ORs for
variables included in the final fitted model for all multip-
arous women who planned their pregnancies. The best
fitting model included the IBI with a cut-point of 5
years, TTP, BMI, barrier methods of contraception and
household monthly income. The Hosmer-Lemeshow
test statistics was 5.0 (df = 8, Prob > chi2 = 0.76) indicat-
ing good calibration.Table 3 Interaction between interbirth interval and the histor






BMI, Body Mass Index; IBI, Interbirth Interval.
*Adjusted for age, BMI, renal disease.IBI as a continuous variable
The findings remained consistent when IBI was treated
as a continuous variable. After adjusting for age, BMI
and renal disease, the odds ratio of having preeclampsia
associated with one year increase in IBI was 1.19 (95%
CI: 1.04-1.37; p = 0.012). The interaction term between
IBI as a continuous variable and the history of previous
preeclampsia was 0.77 (95% CI: 0.58-1.01; p = 0.059).
Among women without history of previous preeclampsia
after adjusting for age, BMI and renal disease, the OR
was 1.32 (95% CI: 1.09-1.59; p < 0.0005), suggesting 32%
increase in the odds of preeclampsia development with
every year increase in IBI among women without history
of previous preeclampsia. Among women with the his-
tory of previous preeclampsia, association between IBI
as a continuous variable and preeclampsia status was
not statistically significant (OR = 1.02; 95% CI: 0.80-1.30;
p = 0.869).
Discussion
This was the first epidemiologic study in Armenia inves-
tigating risk factors for preeclampsia development and
associations of IBI and preeclampsia status. The results
showed that IBI was statistically significantly associated
with preeclampsia status after controlling for con-








0.11 0.60 (0.07-4.99) 0.09
(0.01-1.01) 1.00 (0.01-0.96)
6.88 (1.75-27.05)
Table 4 Final fitted model for preeclampsia in multiparous women who had planned their pregnancies
Variable Univariate analysis Multivariate analysis
Unadjusted OR 95% CI Adjusted OR* 95% CI
IBI (years)
<5 1.00 1.00
≥5 5.26 2.39-11.57 4.49 1.12-17.99
BMI (kg/m2) 1.19 1.11-1.28 1.20 1.04-1.38
Time to pregnancy
<12 months 1.00 1.00
≥12 months 5.40 1.78-16.38 5.99 1.39-25.83
Method of contraception
Non barrier 1.00 1.00




>100,000 5.26 2.39-11.57 4.49 1.12-17.99
AMD, Armenian Dram; BMI, Body Mass Index; IBI, Interbirth Interval.
*Adjusted for all variables in the table.
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of preeclampsia falls sharply after the first birth, the risk
increases over time. Moreover, IBI of five years and more
was associated with seven fold higher odds of pre-
eclampsia development among women without a history
of preeclampsia.
The association of longer than 12 months of TTP and
preeclampsia status was consistent with the results of
the study conducted by the Danish National Birth
Cohort ongoing project among 45,610 women from
1998 to 2001 [22]. This study used TTP for the first time
as a marker of fecundity for the association with pre-
eclampsia status. The present case–control study identi-
fied TTP with cut-point of 12 months being a confounder
for the relationship of IBI and preeclampsia status,
suggesting that longer TTP might explain part of the
increased odds of preeclampsia associated with long IBI.
However, IBI was not adjusted for TTP in this study as
only those women who planned their pregnancies re-
ported TTP (small sample size). Future studies should as-
sess the extent to which the longer TTP might account
for the increased odds associated with long IBI.
The findings regarding increased odds of preeclampsia
associated with increase in IBI were consistent with
other studies that investigated the impact of interbirth
interval on preeclampsia odds without stratifying women
to history of previous preeclampsia [15,17-19]. An im-
portant finding of this study was detecting a statistically
significant interaction between IBI and the history of
previous preeclampsia. All other potential interaction
terms that were investigated were not significant. For
women without a history of previous preeclampsia, theodds of preeclampsia increased in subsequent pregnancy
with increasing time between births whereas for women
with history of previous preeclampsia the odds tended to
decrease with increasing interval between births.
The findings regarding variables included in the final
model as risk factors for preeclampsia development were
consistent with the literature. The identified factors associ-
ated with preeclampeisa development were IBI [15,17-19],
barrier methods of contraception [20], TTP with a cut-
point of 12 months [22], BMI [8,9,15], and household
monthly income [14].
The information regarding all variables included in
our final model is easily measured and does not require
any laboratory tests. Our study failed to investigate the
association of preeclampsia status and diabetes, gesta-
tional diabetes, smoking, marital status, multiple preg-
nancy and partner change because of limited number of
women with these characteristics in the sample. After
excluding women with these characteristics from the
analysis the results did not change.
The study had to rely on hospital records for the diag-
nosis of preeclampsia which is one of the limitations of
the study. Problems with the diagnosis of preeclampsia
involve great observer variability in measuring blood
pressure and the commonly used dipstick analysis of a
random urine sample rather than 24-hour urine analysis
[28]. The process of measuring the exposure was not
independent from the case–control status: the inter-
viewer was aware of the women’s case or control status
which could potentially lead to an interviewer bias.
All medical records were reviewed and uncertain diag-
noses made based on using other than NHLBI criteria
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of false positive diagnoses. Controls were selected by
simple random selection. The same data sources were
used to identify both cases and controls which increased
the confidence that the cases and controls were coming
from the same base population and the groups were
comparable. Incidence-density approach of selecting
controls is one of the strengths of the study. “The ad-
vantage for such an incidence-density selection strategy
of controls is that it establishes comparability between
cases and controls as to follow-up time for the detection
of disease” [29]. Despite the relatively small number of
participants, the actual power calculation demonstrated
that the current sample size provided very high power to
detect the true difference between the groups.Conclusion
The findings of this study showed that each additional
year increase in IBI appeared to be a strong risk factor
for preeclampsia development among women without
history of previous preeclampsia. Further investigation
of the role of the long IBI among women with history
of previous preeclampsia may contribute to a new ap-
proach in understanding the etiology of preeclampsia
and may be useful for developing further recommen-
dations for this particular subgroup of women that
are at higher risk for preeclampsia development in
subsequent pregnancies.Additional file
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